Syon Capital’s AstraZeneca AZN Stock Holding History

Syon Capital’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.29M	Buy	12,068 +110	+0.9%	+$20.7K	0.1%	147
2026 Q1	$2.36M	Buy	11,958 +27	+0.2%	+$5.21K	0.12%	124
2025 Q4	$2.19M	Buy	11,931 +427	+4%	+$74.9K	0.11%	143
2025 Q3	$1.77M	Buy	11,504 +802	+7%	+$121K	0.09%	145
2025 Q2	$1.5M	Buy	10,702 +840	+9%	+$118K	0.1%	145
2025 Q1	$1.45M	Buy	9,862 +853	+9%	+$123K	0.12%	128
2024 Q4	$1.18M	Sell	9,009 -516	-5%	-$72.2K	0.11%	139
2024 Q3	$1.48M	Buy	9,525 +137	+1%	+$22.1K	0.13%	115
2024 Q2	$1.46M	Buy	9,388 +489	+5%	+$73.6K	0.13%	113
2024 Q1	$1.21M	Sell	8,899 -584	-6%	-$77.3K	0.11%	131
2023 Q4	$1.28M	Buy	9,483 +1,477	+18%	+$192K	0.13%	115
2023 Q3	$1.08M	Buy	+8,006	New	+$1.09M	0.14%	96

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Syon Capital's AZN Position: Q2 2026 in Review

Syon Capital increased its AstraZeneca (AZN) stake by 0.92% in Q2 2026, buying an estimated $20.7K and bringing the position to 12,068 shares worth $2.29M. The position accounts for 0.1% of the portfolio, ranked #147.

Syon Capital first reported a position in AZN in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.36M in Q1 2026. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Syon Capital held 12,068 shares of AstraZeneca worth $2.29M as of Q2 2026.
Syon Capital bought 110 AstraZeneca shares in Q2 2026, an estimated $20.7K.
AstraZeneca made up 0.1% of Syon Capital's portfolio in Q2 2026, its #147 holding.
Syon Capital first reported a position in AstraZeneca in Q3 2023 and has held it in 12 quarters since.
Syon Capital's AstraZeneca position peaked at $2.36M in Q1 2026.
1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.